Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-21-008696

CEO and CFO bought 2,700 shares at $36.98 ($99,853)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2021-04-13 Purchase +2,700 $36.98 $99,853 1,189,539 D
Open-market purchases · 2,700 sh · avg $36.98 · $99,853
Loading xslF345X03/ownership.xml…